Ventilator-Associated Pneumonia (VAP)

How VAP develops

A ventilator breathes for a person who cannot breathe adequately alone, through a tube passed through the mouth into the windpipe (endotracheal tube) or through a tracheostomy. The tube saves lives but weakens normal lung defenses:

• The cough reflex and glottis are bypassed, so secretions cannot be cleared normally.
• Secretions pool above the cuff (the inflated balloon that seals the tube), then trickle past it into the lungs (microaspiration).
• Bacteria grow on the tube as a biofilm that is hard for the immune system or antibiotics to reach.
• Sedation and lying flat promote reflux of stomach contents.
• Critical illness weakens immunity.

Risk rises with the time spent on the ventilator, especially in the first 1 to 2 weeks. Other risk factors include older age, chronic lung disease, coma, trauma or burns, reintubation, recent antibiotics, and acid-suppressing medicines.

Germs that cause VAP

• Early VAP (within 4 to 5 days): often bacteria picked up before hospital, such as Streptococcus pneumoniae, Haemophilus influenzae and sensitive Staphylococcus aureus.
• Late VAP (after 5 days): more often hospital bacteria, which may be resistant: MRSA, Pseudomonas aeruginosa, Klebsiella, Enterobacter, Acinetobacter.

Viruses and fungi occasionally cause VAP, particularly in people with weakened immune systems.

Signs of VAP

A ventilated patient cannot describe symptoms, so the ICU team watches for:

• new or returning fever, or a low temperature
• more, thicker, yellow or green secretions suctioned from the tube
• worsening oxygen levels requiring more oxygen or ventilator pressure
• a rising white blood cell count
• faster breathing or heart rate
• a new or growing shadow on chest X-ray

None of these is specific: fluid in the lungs, ARDS, lung collapse and blood clots can look similar, so diagnosis combines several findings.

How VAP is diagnosed

1. Chest X-ray (or CT, or lung ultrasound) showing a new or progressive infiltrate.
2. Respiratory samples: suctioned secretions from the tube (endotracheal aspirate) or, less often, a bronchoscopy wash (bronchoalveolar lavage). Samples are taken before starting antibiotics when possible. Culture shows the bacteria and which antibiotics work.
3. Blood tests: white count, blood cultures, and sometimes procalcitonin.
4. Clinical judgment: scoring systems exist but none is perfect.

For surveillance, US hospitals track ventilator-associated events (VAE), a broader measure of worsening oxygenation after a period of stability.

Treatment

• Antibiotics: started promptly once VAP is suspected. The first choice depends on local resistance patterns, recent antibiotics and the patient's risk of resistant bacteria. Coverage typically includes Pseudomonas and, where common, MRSA. It is then narrowed once cultures return, usually within 48 to 72 hours.
• Duration: a 7-day course is recommended for most patients by IDSA/ATS guidance, rather than longer courses, if they are improving.
• Supportive care: oxygen and ventilator adjustments, suctioning, fluids, and management of sepsis if present.
• Stopping antibiotics if cultures are negative and another explanation is found.

Complications

• longer time on the ventilator and in intensive care
• sepsis and multiple organ failure
• lung abscess or empyema (infected fluid around the lung)
• antibiotic-resistant infections and C. difficile diarrhea from antibiotic use

VAP is associated with higher mortality, though it is hard to separate the effect of the infection from the severity of the illness that required ventilation.

Prevention: the VAP bundle

ICUs use sets of evidence-based steps, called bundles, to lower VAP rates:

• Raise the head of the bed 30 to 45 degrees to reduce reflux and aspiration.
• Daily sedation interruption ("sedation vacation") and spontaneous breathing trials to remove the tube as early as safely possible.
• Avoid unnecessary intubation: use non-invasive ventilation or high-flow oxygen when appropriate.
• Oral care: regular toothbrushing. (Routine chlorhexidine mouthwash is now used more selectively.)
• Subglottic suction tubes: special breathing tubes that drain secretions above the cuff in patients expected to be ventilated for more than 48 to 72 hours.
• Maintaining cuff pressure and avoiding unplanned extubation and reintubation.
• Early mobilization and good hand hygiene.
• Ventilator circuit care: changing circuits only when soiled or broken.

Outlook

Most patients who develop VAP recover with antibiotics and good supportive care, especially when the underlying illness is improving. Survivors of prolonged ventilation often face weeks to months of recovery from weakness, fatigue and breathlessness, known as post-intensive care syndrome. Rehabilitation and follow-up help.

Frequently asked questions

What causes ventilator-associated pneumonia?

VAP is caused by bacteria from the mouth, throat, stomach or breathing tube entering the lungs. The tube keeps the vocal cords open and stops effective coughing, so secretions trickle past the cuff into the airways. Bacteria also form a film on the tube. Longer ventilation increases the risk.

What are the signs of VAP?

In a ventilated patient, signs include a new fever, more or thicker yellow or green secretions, worsening oxygen levels, a rising white blood cell count and a new shadow on the chest X-ray. Because patients are often sedated, ICU teams rely on these measurable changes.

How is ventilator-associated pneumonia treated?

VAP is treated with antibiotics, started quickly and chosen to cover likely hospital bacteria. Once culture results identify the germ, antibiotics are narrowed. Most patients need about 7 days of treatment, along with oxygen and ventilator support and treatment of any sepsis.

How can ventilator-associated pneumonia be prevented?

Prevention bundles include raising the head of the bed 30 to 45 degrees, daily sedation breaks and breathing trials to remove the tube as soon as possible, regular oral care, special tubes that drain secretions above the cuff, careful cuff pressure checks and good hand hygiene.

Is VAP contagious?

VAP itself is not spread like a cold, but the bacteria that cause it, including resistant hospital germs, can spread between patients on hands and equipment. Hand hygiene, gowns and gloves, and careful equipment cleaning protect other patients.